FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2897062932> ?p ?o ?g. }

• W2897062932 abstract "Multicentric Castleman disease (MCD) is an uncommon lymphoproliferative disease characterized by systemic inflammatory reactions associated with the dysregulated production of interleukin-6 (IL-6). In patients with MCD, renal involvement is uncommon, with only one report published regarding kidney transplantation (KTx) to treat end-stage renal disease (ESRD) secondary to MCD. Recent clinical observations have shown that IL-6 production is implicated in allograft rejection, while IL-6 receptor blockade (with tocilizumab [TCZ]) reduces alloantibody generation and thereby improves graft survival; however, the efficacy and safety of TCZ in MCD patients undergoing KTx is still unknown.Herein, we describe the case of a 50-year-old man with MCD who received living-donor KTx for ESRD. Post-operative immunosuppression consisted of a triple-drug regimen (tacrolimus, mycophenolate mofetil and methylprednisolone) with TCZ that was administered intravenously every 2 weeks. At 17 months post-transplantation, the patient remains asymptomatic, and the allograft pathology has shown no evidence of rejection and no development of de novo donor-specific antibody (DSA).To our knowledge, this is the second reported case of an MCD patient with ESRD who underwent successful KTx. TCZ safely supported the patient during the perioperative period, and this drug may be useful for blocking the generation of donor-specific antibodies and reducing the risk of rejection episodes. KTx in combination with TCZ is thus considered a viable treatment option for ESRD due to MCD." @default.
• W2897062932 created "2018-10-26" @default.
• W2897062932 creator A5004884368 @default.
• W2897062932 creator A5017848730 @default.
• W2897062932 creator A5018066068 @default.
• W2897062932 creator A5026485971 @default.
• W2897062932 creator A5029893621 @default.
• W2897062932 creator A5033521669 @default.
• W2897062932 creator A5033933946 @default.
• W2897062932 creator A5034806620 @default.
• W2897062932 creator A5052601493 @default.
• W2897062932 creator A5058133774 @default.
• W2897062932 creator A5058306123 @default.
• W2897062932 creator A5059861327 @default.
• W2897062932 creator A5063147479 @default.
• W2897062932 creator A5065613884 @default.
• W2897062932 date "2018-10-11" @default.
• W2897062932 modified "2023-10-17" @default.
• W2897062932 title "The efficacy and safety of anti-interleukin-6 receptor monoclonal blockade in a renal transplant patient with Castleman disease: early post-transplant outcome" @default.
• W2897062932 cites W1971876954 @default.
• W2897062932 cites W1982628467 @default.
• W2897062932 cites W2010974628 @default.
• W2897062932 cites W2023761225 @default.
• W2897062932 cites W2029914290 @default.
• W2897062932 cites W2069832923 @default.
• W2897062932 cites W2080693971 @default.
• W2897062932 cites W2150642904 @default.
• W2897062932 cites W2153798731 @default.
• W2897062932 cites W2154268960 @default.
• W2897062932 cites W2285565588 @default.
• W2897062932 cites W2412036489 @default.
• W2897062932 cites W2481588233 @default.
• W2897062932 cites W2482118571 @default.
• W2897062932 cites W2512510124 @default.
• W2897062932 cites W2574733167 @default.
• W2897062932 cites W2586251631 @default.
• W2897062932 cites W2588200867 @default.
• W2897062932 cites W412766306 @default.
• W2897062932 cites W1606363524 @default.
• W2897062932 doi "https://doi.org/10.1186/s12882-018-1065-4" @default.
• W2897062932 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6186080" @default.
• W2897062932 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30314457" @default.
• W2897062932 hasPublicationYear "2018" @default.
• W2897062932 type Work @default.
• W2897062932 sameAs 2897062932 @default.
• W2897062932 citedByCount "11" @default.
• W2897062932 countsByYear W28970629322020 @default.
• W2897062932 countsByYear W28970629322021 @default.
• W2897062932 countsByYear W28970629322022 @default.
• W2897062932 countsByYear W28970629322023 @default.
• W2897062932 crossrefType "journal-article" @default.
• W2897062932 hasAuthorship W2897062932A5004884368 @default.
• W2897062932 hasAuthorship W2897062932A5017848730 @default.
• W2897062932 hasAuthorship W2897062932A5018066068 @default.
• W2897062932 hasAuthorship W2897062932A5026485971 @default.
• W2897062932 hasAuthorship W2897062932A5029893621 @default.
• W2897062932 hasAuthorship W2897062932A5033521669 @default.
• W2897062932 hasAuthorship W2897062932A5033933946 @default.
• W2897062932 hasAuthorship W2897062932A5034806620 @default.
• W2897062932 hasAuthorship W2897062932A5052601493 @default.
• W2897062932 hasAuthorship W2897062932A5058133774 @default.
• W2897062932 hasAuthorship W2897062932A5058306123 @default.
• W2897062932 hasAuthorship W2897062932A5059861327 @default.
• W2897062932 hasAuthorship W2897062932A5063147479 @default.
• W2897062932 hasAuthorship W2897062932A5065613884 @default.
• W2897062932 hasBestOaLocation W28970629321 @default.
• W2897062932 hasConcept C126322002 @default.
• W2897062932 hasConcept C126894567 @default.
• W2897062932 hasConcept C141071460 @default.
• W2897062932 hasConcept C2777178219 @default.
• W2897062932 hasConcept C2777910003 @default.
• W2897062932 hasConcept C2778063415 @default.
• W2897062932 hasConcept C2779134260 @default.
• W2897062932 hasConcept C2780252810 @default.
• W2897062932 hasConcept C2780303639 @default.
• W2897062932 hasConcept C2909675724 @default.
• W2897062932 hasConcept C2911091166 @default.
• W2897062932 hasConcept C3019040382 @default.
• W2897062932 hasConcept C54847362 @default.
• W2897062932 hasConcept C71924100 @default.
• W2897062932 hasConcept C90924648 @default.
• W2897062932 hasConceptScore W2897062932C126322002 @default.
• W2897062932 hasConceptScore W2897062932C126894567 @default.
• W2897062932 hasConceptScore W2897062932C141071460 @default.
• W2897062932 hasConceptScore W2897062932C2777178219 @default.
• W2897062932 hasConceptScore W2897062932C2777910003 @default.
• W2897062932 hasConceptScore W2897062932C2778063415 @default.
• W2897062932 hasConceptScore W2897062932C2779134260 @default.
• W2897062932 hasConceptScore W2897062932C2780252810 @default.
• W2897062932 hasConceptScore W2897062932C2780303639 @default.
• W2897062932 hasConceptScore W2897062932C2909675724 @default.
• W2897062932 hasConceptScore W2897062932C2911091166 @default.
• W2897062932 hasConceptScore W2897062932C3019040382 @default.
• W2897062932 hasConceptScore W2897062932C54847362 @default.
• W2897062932 hasConceptScore W2897062932C71924100 @default.
• W2897062932 hasConceptScore W2897062932C90924648 @default.
• W2897062932 hasIssue "1" @default.
• W2897062932 hasLocation W28970629321 @default.
• W2897062932 hasLocation W28970629322 @default.
• W2897062932 hasLocation W28970629323 @default.

• next